Abstract:Abstract Background Alternative splicing isoforms have been reported as a new and robust class of diagnostic biomarkers. Over 95% of human genes are estimated to be alternatively spliced as a powerful means of producing functionally diverse proteins from a single gene. The emergence of next-generation sequencing technologies, especially RNA-seq, provides novel insights into large-scale detection and analysis of alternative splicing at the transcriptional level. Advances in Proteomic Technologies such as liquid chromatography coupled tandem mass spectrometry (LC–MS/MS), have shown tremendous power for the parallel characterization of large amount of proteins in biological samples. Although poor correspondence has been generally found from previous qualitative comparative analysis between proteomics and microarray data, significantly higher degrees of correlation have been observed at the level of exon. Combining protein and RNA data by searching LC–MS/MS data against a customized protein database from RNA-Seq may produce a subset of alternatively spliced protein isoform candidates that have higher confidence. Results We developed a bioinformatics workflow to discover alternative splicing biomarkers from LC–MS/MS using RNA-Seq. First, we retrieved high confident, novel alternative splicing biomarkers from the breast cancer RNA-Seq database. Then, we translated these sequences into in silico Isoform Junction Peptides , and created a customized alternative splicing database for MS searching. Lastly, we ran the Open Mass spectrometry Search Algorithm against the customized alternative splicing database with breast cancer plasma proteome. Twenty six alternative splicing biomarker peptides with one single intron event and one exon skipping event were identified. Further interpretation of biological pathways with our Integrated Pathway Analysis Database showed that these 26 peptides are associated with Cancer, Signaling, Metabolism, Regulation, Immune System and Hemostasis pathways, which are consistent with the 256 alternative splicing biomarkers from the RNA-Seq. Conclusions This paper presents a bioinformatics workflow for using RNA-seq data to discover novel alternative splicing biomarkers from the breast cancer proteome. As a complement to synthetic alternative splicing database technique for alternative splicing identification, this method combines the advantages of two platforms: mass spectrometry and next generation sequencing and can help identify potentially highly sample-specific alternative splicing isoform biomarkers at early-stage of cancer.

Identification of Alternatively Spliced Mrna Variants Related to Cancers by Genome-Wide ESTs Alignment

A Global View of Cancer-Specific Transcript Variants by Subtractive Transcriptome-Wide Analysis

Pan-cancer Analysis of Clinical Relevance of Alternative Splicing Events in 31 Human Cancers

A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients

OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers

Genome-wide identification of pan-cancer common and cancer-specific alternative splicing events in 9 types of cancer

Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors

ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers

Genome-wide detection of testis- and testicular cancer-specific alternative splicing

Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq

Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.

LncAS2Cancer: a Comprehensive Database for Alternative Splicing of Lncrnas Across Human Cancers

Identification of Novel Alternative Splicing Isoform Biomarkers and Their Association with Overall Survival in Colorectal Cancer

CancerSplicingQTL: a Database for Genome-Wide Identification of Splicing QTLs in Human Cancer

Systematic Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Prostate Cancer

Survival-associated alternative splicing signatures in esophageal carcinoma

Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.

Transcriptome-Wide Analysis Reveals The Landscape Of Aberrant Alternative Splicing Events In Liver Cancer

Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets

Comprehensive Network Analysis Reveals Alternative Splicing-Related Lncrnas in Hepatocellular Carcinoma

OncoSplicing 3.0: an Updated Database for Identifying RBPs Regulating Alternative Splicing Events in Cancers.